Results 261 to 270 of about 484,106 (362)
Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer. [PDF]
Rebouças CV+4 more
europepmc +1 more source
Abstract Belumosudil is an oral selective rho‐associated coiled‐coil containing protein kinase 2 inhibitor, approved as a treatment for chronic graft‐versus‐host disease. Prior clinical studies demonstrated that coadministration with strong CYP3A4 inducers or proton pump inhibitors requires dose modification of belumosudil.
Olivier Schueller+4 more
wiley +1 more source
Severe gastrointestinal manifestations in childhood-onset lupus: A single-center cohort and review of the literature. [PDF]
Orozco J+6 more
europepmc +1 more source
Abstract This study aimed to characterize the pharmacokinetics (PK) of etrolizumab, an IgG1‐humanized monoclonal anti‐β7 integrin antibody, and assess its exposure–response (ER) relationship for key clinical outcomes in patients with moderately‐to‐severely active Crohn's disease.
Anita Moein+4 more
wiley +1 more source
Neurocognitive risks of asthma during childhood. [PDF]
Christopher-Hayes NJ, Ghetti S.
europepmc +1 more source
We present the case of an elderly male with bullous pemphigoid, initially negative for the anti‐BP180‐NC16a antibody, which later became positive as disease activity progressed. The patient was successfully managed at home through multidisciplinary collaboration, including a general practitioner, dermatologist, nurses, and pharmacists.
Hiromitsu Yamashita+3 more
wiley +1 more source
Development of a guideline for orthopaedic management in the care of children and young people with Duchenne muscular dystrophy in the UK National Health Service. [PDF]
Henman PD+20 more
europepmc +1 more source
This study revealed that a glucometer‐based measurement significantly improved the turnaround time required for CSF/serum glucose ratio measurement compared to conventional laboratory tests, which could be considered a reliable aid to the mortality prognosis.
Nasrin Khodashenas+3 more
wiley +1 more source